Lifeboat Foundation

Just in time for Halloween’s spooky season, a quantum sensor now has double the spookiness by combining entanglement between atoms and delocalization of atoms.

Future quantum sensors will be able to provide more precise navigation, explore for needed natural resources, more precisely determine fundamental constants, look more precisely for dark matter, or maybe someday discover gravitational waves thanks to a team of researchers led by Fellow James K. Thompson from the Joint Institute for Laboratory Astrophysics (JILA) and the National Institute of Standards and Technology (NIST).

Thompson and his team have for the first time successfully combined two of the “spookiest” features of quantum mechanics: entanglement between atoms and delocalization of atoms. By doubling down on these “spooky” features, better quantum sensors can be made.

Continue reading “In a world first, researchers combine two of the ‘spookiest’ features of quantum mechanics” »

“The project has certainly been a rewarding exercise in bringing art and science together.”

The magnetic signals from the ESA’s Swarm satellite project were turned into sound by researchers at the Technical University of Denmark. The outcome is quite thrilling for something that is supposed to protect us.

“The team used data from ESA’s Swarm satellites and other sources and used these magnetic signals to manipulate and control a sonic representation of the core field. The project has certainly been a rewarding exercise in bringing art and science together,” musician and project supporter Klaus Nielsen, from the Technical University of Denmark, explained the project in the ESA’s release. team used data from ESA’s Swarm satellites and other sources and used these magnetic signals to manipulate and control a sonic representation of the core field. The project has certainly been a rewarding exercise in bringing art and science together,” musician and project supporter Klaus Nielsen, from the Technical University of Denmark, explained the project in the ESA’s release.

The ongoing saga between Elon Musk and Twitter is set to come to an end this week as he needs to finalize the purchase by October 28th, 2022.

The latest update on Elon Musk’s plan to buy Twitter is that this week could be a turning point. It may even see the deal finally sealed.

Continue reading “Elon Musk’s Twitter deal may be finalized this week. Here’s what to expect” »

Put horror movies and games aside for a few minutes to listen to something truly unsettling this Halloween season. The has released audio of what our planet’s magnetic field sounds like. While it protects us from cosmic radiation and charged particles from solar winds, it turns out that the magnetic field has an unnerving rumble.

You can’t exactly point a microphone at the sky and hear the magnetic field (nor can we see it). Scientists from the Technical University of Denmark collected by the ESA’s three Swarm satellites into sound, representing both the magnetic field and a solar storm.

Continue reading “Listen to the eerie sounds of a solar storm hitting the Earth’s magnetic field” »

Our immune system is the first line of defense against disease, but unfortunately it can go rogue and attack healthy tissues. Scientists at Johns Hopkins University have now engineered a protein that may help prevent these autoimmune diseases by boosting the number of regulatory T cells (Tregs).

The immune system keeps a vigilant watch over our bodies at all times, tagging and destroying foreign pathogens or problematic cells to prevent illness. However, sometimes it can get a little overzealous and start attacking the body’s own cells, which can trigger a range of autoimmune diseases like type 1 diabetes, lupus and rheumatoid arthritis.

To prevent these issues from arising, immune cells called Tregs play the vital role of keeping the immune system responses in check, but they can fail at this job. So for the new study, the researchers set out to boost their numbers, following previous studies that have shown promise in doing so to help treat autoimmune diseases like multiple sclerosis and Crohn’s disease.

In the past decades, the number of known exoplanets—planets in other solar systems—has skyrocketed. But we’re still in the dark about a number of details, including how massive they are and what they’re made up of.

A University of Chicago undergraduate, however, was able to tease some clues out of data that most scientists had overlooked.

Jared Siegel, B.S. ‘22, spent six months analyzing data taken by a NASA spacecraft. Some of this data was full of statistical noise, making it hard to differentiate planets from other phenomena; but Siegel and his advisor, astrophysicist Leslie Rogers, were able to extract useful information about these planets, setting an upper bound on how massive they could be.

India launches it’s own rocket in place of Soyuz-article here.

India’s most powerful rocket, the GSLV Mk.3, launched 36 OneWeb internet satellites at 2:37 p.m. EDT (1837 GMT) Saturday. The mission resumed launches for OneWeb after the suspension of flights on Russian Soyuz rockets earlier this year.

Quarks all the way down.

Astronomers recently discovered that this neutron star left behind by the collapse and explosion of a supergiant is now roughly 77 percent the mass of our Sun, packed into a sphere about 10 kilometers wide. That’s a mind-bogglingly dense ball of matter — it’s squished together so tightly that it doesn’t even have room to be atoms, just neutrons. But as neutron stars go, it’s weirdly lightweight. Figuring out why that’s the case could reveal fascinating new details about exactly what happens when massive stars collapse and explode.

What’s New — When a massive star collapses, it triggers an explosion that blasts most of the star’s outer layers out into space, where they form an ever-widening cloud of hot, glowing gas. The heart of the star, however, gets squashed together in the final pressure of that collapse and becomes a neutron star. Normally, what’s left behind is something between 1.17 and 2.35 times as massive as the Sun, crammed into a ball a few dozen kilometers wide.

The deal, which was formally signed on the sidelines of the World Cancer Congress in Geneva this week, marks the first time a pharmaceutical company is making a patented cancer medicine available through a voluntary licensing scheme. “This is important because it’s the first and helps show that voluntary licences can work for cancer drugs,” Charles Gore, the executive director of the Medicines Patent Pool (MPP), told SWI swissinfo.ch.

Swiss pharma giant Novartis has finalised a deal to allow generic production of its patented drug nilotinib to treat chronic myeloid leukemia.